Total Payments
$942.62
2024 Payments
$120.06
Companies
8
Transactions
35
Medicare Patients
601
Medicare Billing
$44,669
Payment Breakdown by Category
Food & Beverage$942.62 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $942.62 | 35 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $419.55 | 11 | $0 (2023) |
| Supernus Pharmaceuticals, Inc. | $174.32 | 8 | $0 (2024) |
| ABBVIE INC. | $157.01 | 10 | $0 (2023) |
| Lilly USA, LLC | $122.09 | 1 | $0 (2022) |
| Hologic Sales and Service, LLC | $28.67 | 2 | $0 (2024) |
| Amgen Inc. | $19.64 | 1 | $0 (2021) |
| Abbott Laboratories | $14.66 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $120.06 | 5 | Supernus Pharmaceuticals, Inc. ($91.92) |
| 2023 | $49.96 | 4 | Hologic Sales and Service, LLC ($15.19) |
| 2022 | $270.56 | 7 | Novo Nordisk Inc ($148.47) |
| 2021 | $502.04 | 19 | Novo Nordisk Inc ($256.67) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/03/2024 | Hologic Sales and Service, LLC | ACESSA PROVU SYSTEM (Device), OMNI HYSTEROSCOPE | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Surgical | ||||||
| 04/24/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Diabetes Care | ||||||
| 01/18/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 01/09/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $60.36 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 01/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 06/21/2023 | Hologic Sales and Service, LLC | OMNI HYSTEROSCOPE (Device) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Surgical | ||||||
| 06/08/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Obesity | ||||||
| 03/17/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: NEUROSCIENCE | ||||||
| 02/15/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $6.68 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/27/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $8.21 | General |
| Category: Diabetes | ||||||
| 07/28/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $122.09 | General |
| Category: Diabetes | ||||||
| 07/21/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $9.13 | General |
| Category: Diabetes | ||||||
| 03/23/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $109.65 | General |
| Category: Diabetes | ||||||
| 02/18/2022 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: Obesity | ||||||
| 02/02/2022 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $7.70 | General |
| Category: Obesity | ||||||
| 02/02/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $1.90 | General |
| Category: Obesity | ||||||
| 12/16/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $18.71 | General |
| Category: PSYCHOLOGY | ||||||
| 11/30/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $98.27 | General |
| Category: NEUROSCIENCE | ||||||
| 11/30/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.33 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: NEUROSCIENCE | ||||||
| 11/10/2021 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $7.36 | General |
| Category: Obesity | ||||||
| 10/29/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.89 | General |
| Category: NEUROSCIENCE | ||||||
| 10/27/2021 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $122.11 | General |
| Category: Diabetes | ||||||
| 10/02/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.73 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2021 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $18.97 | General |
| Category: AED | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 207 | 254 | $36,075 | $17,270 |
| 2022 | 4 | 111 | 154 | $20,525 | $8,515 |
| 2021 | 7 | 158 | 208 | $29,121 | $12,065 |
| 2020 | 5 | 125 | 169 | $20,695 | $6,820 |
Total Patients
601
Total Services
785
Medicare Billing
$44,669
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 69 | 112 | $19,040 | $7,064 | 37.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 11 | 11 | $3,355 | $3,092 | 92.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 30 | 30 | $4,950 | $3,063 | 61.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 54 | $6,480 | $2,049 | 31.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 18 | 18 | $1,525 | $1,291 | 84.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 18 | 18 | $450.00 | $441.00 | 98.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 11 | 11 | $275.00 | $269.50 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 47 | 78 | $13,260 | $5,360 | 40.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 49 | $5,880 | $1,923 | 32.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 12 | 13 | $1,035 | $887.74 | 85.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 13 | 14 | $350.00 | $343.50 | 98.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 49 | 74 | $12,580 | $4,440 | 35.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 44 | 68 | $8,160 | $3,102 | 38.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 17 | 17 | $4,165 | $2,334 | 56.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 11 | 11 | $1,815 | $1,186 | 65.4% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 13 | 13 | $970.00 | $713.58 | 73.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 12 | 12 | $300.00 | $190.00 | 63.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 12 | 13 | $1,131 | $99.42 | 8.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 42 | 69 | $11,730 | $3,854 | 32.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 39 | 54 | $6,480 | $1,533 | 23.7% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 15 | 15 | $1,050 | $853.72 | 81.3% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 11 | 12 | $960.00 | $293.80 | 30.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 18 | 19 | $475.00 | $285.02 | 60.0% |
About Susan Rexing
Susan Rexing is a Family healthcare provider based in Fishers, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285699801.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Susan Rexing has received a total of $942.62 in payments from pharmaceutical and medical device companies, with $120.06 received in 2024. These payments were reported across 35 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($942.62).
As a Medicare-enrolled provider, Rexing has provided services to 601 Medicare beneficiaries, totaling 785 services with total Medicare billing of $44,669. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Nurse Practitioner
- Location Fishers, IN
- Active Since 04/18/2006
- Last Updated 05/14/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1285699801
Products in Payments
- VRAYLAR (Drug) $143.33
- Rybelsus (Drug) $126.99
- Ozempic (Drug) $122.11
- MOUNJARO (Drug) $122.09
- RYBELSUS (Drug) $102.40
- Qelbree (Drug) $91.92
- Wegovy (Drug) $66.15
- QELBREE (Drug) $50.31
- Otezla (Drug) $19.64
- OXTELLAR XR (Drug) $18.97
- OMNI HYSTEROSCOPE (Device) $15.19
- FREESTYLE LIBRE 3 (Device) $14.66
- QULIPTA (Drug) $13.68
- ACESSA PROVU SYSTEM (Device) $13.48
- TROKENDI XR (Drug) $13.12
- Azstarys (Drug) $6.68
- Saxenda (Drug) $1.90
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Fishers
Mrs. Katelyn Hooker, Fnp-C, FNP-C
Family — Payments: $9,614
Family $9,614
Mallory Bragg, Fnp-C, FNP-C
Family — Payments: $9,369
Family $9,369
Laura Sink, Np, NP
Family — Payments: $3,844
Family $3,844
Nieasha Richardson, Apn, APN
Family — Payments: $2,628
Family $2,628
Bonnie Webster, Nurse Practitioner, NURSE PRACTITIONER
Family — Payments: $2,200
Family $2,200
Mrs. Kristy Umana, Np, NP
Family — Payments: $1,409
Family $1,409